Dendritic cells: at the clinical crossroads
Open Access
- 15 March 2000
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 105 (6) , 707-708
- https://doi.org/10.1172/jci9591
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopesJournal of Clinical Investigation, 2000
- Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV MelanomaThe Journal of Experimental Medicine, 1999
- Differentiation of Phagocytic Monocytes into Lymph Node Dendritic Cells In VivoImmunity, 1999
- In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral AreasThe Journal of Experimental Medicine, 1999
- Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells.1999
- Dendritic cells and the control of immunityNature, 1998
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigenThe Prostate, 1996
- Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cellsNature Medicine, 1996
- Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.Journal of Clinical Investigation, 1994